<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03448315</url>
  </required_header>
  <id_info>
    <org_study_id>405</org_study_id>
    <nct_id>NCT03448315</nct_id>
  </id_info>
  <brief_title>Role of Transcrainal Direct Current Brain Stimulation in Acute and Chronic Post-mastectomy Pain Management</brief_title>
  <official_title>Role of Transcrainal Direct Current Brain Stimulation in Acute and Chronic Post-mastectomy Pain Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the role of transcranial magnetic stimulation over the primary motor cortex area on acute&#xD;
      postoperative pain after breast cancer surgery and on the probability of developing chronic&#xD;
      neuropathic pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      New analgesic strategies are needed that can be used adjunctively to existing strategies with&#xD;
      the potential to reduce reliance on opioid analgesia. Several novel brain stimulation&#xD;
      technologies including transcranial direct current stimulation (tDCS) are beginning to&#xD;
      demonstrate promise as treatments for a variety of pain conditions. Electricity has no&#xD;
      metabolite or other residue, and can be delivered with minimal discomfort and without&#xD;
      problems associated with drug-drug interactions.Transcranial direct current stimulation has&#xD;
      been studied in patients with various disorders and multiple pain syndromes. There is also&#xD;
      evidence that tDCS might be useful in postsurgical pain reduction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2, 2017</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total morphine comsuption</measure>
    <time_frame>48 hours</time_frame>
    <description>the total dose of morphine used as analgesic expressed in mg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>baseline,at 2,4,6, 12, 24,36,48 hours</time_frame>
    <description>patient asked to describe this pain with scores ranging from 0 to10 (with 0 = no pain and 10 = the worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Douleur Neuropathique 4 questions DN4</measure>
    <time_frame>1month, 3month, 6 month</time_frame>
    <description>the possibility of development of neuropathic pain will be assessed using DN4 scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>real tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>motor cortex stimulation (2 mA, 20 min for 4 sessions)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>motor cortex stimulation (2 mA, 20 min for 4 sessions) but stimulation device is turned off without the participant knowledge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <description>motor cortex stimulation (2 mA, 20 min for 4 sessions)</description>
    <arm_group_label>real tDCS</arm_group_label>
    <arm_group_label>sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I-II, scheduled for unilateral modified radical mastectomy with axillary&#xD;
             dissection for breast cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with intracranial metallic devices or with pacemakers or any other device.&#xD;
&#xD;
          -  patients with Neurological or psychiatric disorders,&#xD;
&#xD;
          -  patients taking major centrally acting drugs (antiepileptics or antidepressants),&#xD;
             -opioid dependence,&#xD;
&#xD;
          -  substance abuse,&#xD;
&#xD;
          -  severe cardiopulmonary, renal, hepatic diseases, and&#xD;
&#xD;
          -  those with extensive myocardial ischemia or unstable angina.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>South Egypt Cancer Institute</name>
      <address>
        <city>Assiut</city>
        <zip>11715</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>February 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2018</study_first_posted>
  <last_update_submitted>October 14, 2020</last_update_submitted>
  <last_update_submitted_qc>October 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Shereen Mamdouh</investigator_full_name>
    <investigator_title>Lectruer of anesthesia, ICU and pain manegement</investigator_title>
  </responsible_party>
  <keyword>brain stimulation, tDCS, acute postoperative pain, chronic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

